Valuation: Eckert & Ziegler SE

Market Cap 753M 869M 712M 646M 1.21B 83.33B 1.22B 8.49B 3.28B 42.27B 3.26B 3.19B 135B P/E 2026 *
14.7x
P/E 2027 * 13.9x
Enterprise Value 637M 735M 602M 547M 1.02B 70.52B 1.03B 7.19B 2.78B 35.77B 2.76B 2.7B 114B EV / Sales 2026 *
2x
EV / Sales 2027 * 1.84x
Free-Float
67.36%
Yield 2026 *
1.75%
Yield 2027 * 1.79%
1 day-1.94%
1 week-2.29%
Current month-6.93%
1 month-10.83%
3 months-19.62%
6 months-17.09%
Current year-20.20%
1 week 12.09
Extreme 12.09
12.48
1 month 12.09
Extreme 12.09
13.69
Current year 12.09
Extreme 12.09
16.82
1 year 12.09
Extreme 12.09
18.75
3 years 9.67
Extreme 9.666666
23.07
5 years 9.67
Extreme 9.666666
46.73
10 years 1.73
Extreme 1.728749
46.92
Manager TitleAgeSince
Chief Executive Officer 59 2023-06-06
Chief Tech/Sci/R&D Officer - 2024-12-31
Chief Operating Officer 59 2024-12-31
Director TitleAgeSince
Chairman 57 2023-06-06
Director/Board Member 66 2013-12-31
Director/Board Member 58 2016-12-31
Change 5-day change 1-year change 3-year change Capi.($)
-1.94%-2.29% - - 886M
+1.59%+2.36%+22.92%-30.44% 17.14B
-0.23%+10.16%-44.30%+53.83% 1.88B
-1.88%-3.37%-30.94%+15.52% 886M
0.00%-0.16%+58.81%-2.02% 778M
+1.32%-14.79%-63.53%-85.78% 729M
0.00%-5.30%-39.39%-51.20% 631M
+1.52%-4.78%-43.79%-54.61% 567M
+3.16%+2.19%-44.43%-39.93% 425M
-0.50%+2.37%+61.04%+55.97% 412M
Average +0.30%-2.96%-13.73%-15.41% 2.61B
Weighted average by Cap. +1.08%+1.24%+10.15%-22.51%

Financials

2026 *2027 *
Net sales 318M 367M 301M 273M 511M 35.2B 514M 3.59B 1.39B 17.85B 1.38B 1.35B 56.91B 342M 394M 323M 293M 550M 37.84B 553M 3.86B 1.49B 19.19B 1.48B 1.45B 61.17B
Net income 51.68M 59.64M 48.85M 44.34M 83.11M 5.72B 83.61M 583M 225M 2.9B 224M 219M 9.25B 53.08M 61.26M 50.17M 45.55M 85.37M 5.88B 85.88M 599M 231M 2.98B 230M 225M 9.5B
Net Debt -116M -134M -109M -99.33M -186M -12.81B -187M -1.31B -505M -6.5B -502M -491M -20.72B -123M -141M -116M -105M -197M -13.56B -198M -1.38B -534M -6.88B -531M -519M -21.92B
Logo Eckert & Ziegler SE
Eckert & Ziegler SE is a Germany-based Company, which is a provider of isotope technology for medical, scientific and industrial use with focus on cancer therapy, industrial radiometry and nuclear-medical imaging. The Company operates through three segments: Radiation Therapy, Isotope Products and Radiopharma. The Radiation Therapy segment operates through Eckert & Ziegler BEBIG and produces and distributes medical products for the treatment of cancer using brachytherapy. The Isotope Products segment provides sealed and unsealed radiation sources for medical imaging, industrial gauging, measurement and analysis, reference, calibration and environmental monitoring sources and solutions, as well as bulk radioisotopes for pharmaceutical, therapeutic and industrial product manufacturers. The Radiopharma segment specializes in molecular imaging and nuclear medicine, and supplies various radiopharmaceuticals, radiochemicals and related equipment.
Employees
1,105
Date Price Change Volume
26-09-16 €12.10 -1.87% 3,803
26-09-15 €12.33 0.00% 401
26-09-14 €12.33 +0.57% 2,543
26-09-11 €12.26 -0.33% 1,121
26-09-10 €12.30 -1.05% 3,636
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
12.03EUR
Average target price
21.60EUR
Spread / Average Target
+79.55%

Annual profits - Rate of surprise

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!